Insider · CIK 0001413306

Grais Linda

Reports to the SEC for 8 companies · DUBLIN

sec.gov

Transactions

Companies

Filings

CIK

0001413306

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-11	ICLRICON PLCS Sale	Director	SSale	−590 sh	$164.47	−$97K	6,229
2026-08-11	ICLRICON PLCS Sale	Director	SSale	−67 sh	$165.51	−$11.1K	6,162
2026-08-11	ICLRICON PLCS Sale	Director	SSale	−87 sh	$162.72	−$14.2K	6,916
2026-08-11	ICLRICON PLCS Sale	Director	SSale	−97 sh	$163.77	−$15.9K	6,819
2026-08-10	ICLRICON PLCM Exercise/Conversion	Director	MExercise/Conversion	+1,732 sh	—	—	7,003
2026-08-10	ICLRICON PLC · Restricted Share UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,732 sh	—	—	0
2026-08-10	ICLRICON PLC · Restricted Share UnitsA Award	Director	AAward	+1,324 sh	—	—	1,324
2026-06-11	CRVSCorvus Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2025-06-12	CRVSCorvus Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2024-06-13	CRVSCorvus Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2024-01-30	ORKAOruka Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2023-12-06	CRVSCorvus Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2023-06-15	CRVSCorvus Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2023-05-15	CRVSCorvus Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+10K sh	$2.45	+$24.5K	10,000
2022-12-15	ORKAOruka Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2022-08-11	CRVSCorvus Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2022-06-15	CRVSCorvus Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2021-09-09	CRVSCorvus Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2021-07-01	PRA Health Sciences, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−9,683 sh	—	—	0
2021-06-15	CRVSCorvus Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2021-06-10	Zosano Pharma CorpStock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2021-06-10	Zosano Pharma CorpA Award	Director	AAward	+15K sh	—	—	22,500
2021-06-01	PRA Health Sciences, Inc.A Award	Director	AAward	+250 sh	—	—	9,683
2021-01-12	ORKAOruka Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+12K sh	—	—	12,000
2020-06-25	Zosano Pharma CorpA Award	Director	AAward	+7,500 sh	—	—	7,500
2020-06-09	CRVSCorvus Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2020-06-03	Zosano Pharma CorpStock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2020-06-03	Zosano Pharma CorpStock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2020-05-18	PRA Health Sciences, Inc.A Award	Director	AAward	+1,324 sh	—	—	9,433
2020-03-19	CRVSCorvus Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2019-06-20	CRVSCorvus Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2019-06-03	PRA Health Sciences, Inc.A Award	Director	AAward	+1,436 sh	—	—	8,109
2019-01-28	CRVSCorvus Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2019-01-14	Zosano Pharma CorpStock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2018-06-21	PRA Health Sciences, Inc.A Award	Director	AAward	+1,307 sh	—	—	6,673
2018-03-01	ORKAOruka Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+8,000 sh	—	—	8,000
2017-12-11	Ocera Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−160K sh	—	—	0
2017-12-11	Ocera Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−37.5K sh	—	—	0
2017-12-11	Ocera Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−30.8K sh	—	—	0
2017-12-11	Ocera Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−30.8K sh	—	—	0
2017-12-11	Ocera Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−12K sh	—	—	0
2017-12-11	Ocera Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−349K sh	—	—	0
2017-12-11	Ocera Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−289K sh	—	—	0
2017-12-11	Ocera Therapeutics, Inc.D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−70K sh	$1.52	−$106K	0
2017-12-11	Ocera Therapeutics, Inc.D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−230K sh	$1.52	−$350K	0
2017-12-11	Ocera Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−492K sh	—	—	0
2017-07-12	PRA Health Sciences, Inc.A Award	Director	AAward	+1,318 sh	—	—	5,366
2017-03-29	Ocera Therapeutics, Inc.A Award	Director, President and CEO	AAward	+230K sh	—	—	300,000
2017-02-16	ORKAOruka Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+8,000 sh	—	—	8,000
2016-12-15	Ocera Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+289K sh	—	—	289,200

Recent filings

Accepted (ET)
Aug 124
Grais Linda0001628280-26-056304
SEC(opens sec.gov)
Jun 154
Grais Linda0001610717-26-000221
SEC(opens sec.gov)
Jun 164
Grais Linda0001610717-25-000233
SEC(opens sec.gov)
Jun 174
Grais Linda0001610717-24-000345
SEC(opens sec.gov)
Jan 314
Grais Linda0001209191-24-002477
SEC(opens sec.gov)
Dec 84
Grais Linda0001610717-23-000390
SEC(opens sec.gov)
Jun 204
Grais Linda0001610717-23-000185
SEC(opens sec.gov)
May 164
Grais Linda0001610717-23-000041
SEC(opens sec.gov)
Dec 194
Grais Linda0001209191-22-061908
SEC(opens sec.gov)
Aug 154
Grais Linda0001567619-22-016296
SEC(opens sec.gov)
Jun 174
Grais Linda0001567619-22-013139
SEC(opens sec.gov)
Sep 134
Grais Linda0001567619-21-017012
SEC(opens sec.gov)
Jul 14
Grais Linda0001104659-21-088348
SEC(opens sec.gov)
Jun 164
Grais Linda0001567619-21-012197
SEC(opens sec.gov)

Companies

Address

C/O ICON PLC SOUTH COUNTY BUSINESS PARK, LEOPARDSTOWN

DUBLIN, D18X5R3